Tomer Adar

1.5k total citations
57 papers, 976 citations indexed

About

Tomer Adar is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Tomer Adar has authored 57 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 14 papers in Epidemiology and 10 papers in Genetics. Recurrent topics in Tomer Adar's work include Liver Disease Diagnosis and Treatment (8 papers), Gastrointestinal disorders and treatments (6 papers) and Inflammatory Bowel Disease (6 papers). Tomer Adar is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Gastrointestinal disorders and treatments (6 papers) and Inflammatory Bowel Disease (6 papers). Tomer Adar collaborates with scholars based in Israel, United States and Italy. Tomer Adar's co-authors include Meir Mizrahi, Yaron Ilan, Ami Ben Yaʼacov, Gadi Lalazar, Eran Goldin, Ariella Bar‐Gil Shitrit, Oren Shibolet, Daniel C. Chung, Kristen M. Shannon and Linda Rodgers and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Cancer.

In The Last Decade

Tomer Adar

55 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomer Adar Israel 19 345 302 221 187 140 57 976
Kunihiko Murase Japan 15 365 1.1× 382 1.3× 67 0.3× 150 0.8× 130 0.9× 52 1.0k
Nasir Mahmud Ireland 17 282 0.8× 357 1.2× 381 1.7× 165 0.9× 85 0.6× 33 1.1k
Kazuo Ohba Japan 16 574 1.7× 444 1.5× 86 0.4× 130 0.7× 118 0.8× 48 1.4k
Ömer Özbakır Türkiye 17 304 0.9× 185 0.6× 100 0.5× 47 0.3× 118 0.8× 44 893
Mine Güllüoğlu Türkiye 20 296 0.9× 478 1.6× 79 0.4× 154 0.8× 358 2.6× 118 1.4k
Dajun Qian United States 19 256 0.7× 264 0.9× 247 1.1× 85 0.5× 189 1.4× 38 1.3k
James L. Wisecarver United States 21 268 0.8× 255 0.8× 105 0.5× 171 0.9× 335 2.4× 69 1.3k
Ali Tüzün İnce Türkiye 17 270 0.8× 468 1.5× 70 0.3× 91 0.5× 185 1.3× 65 934
Stefano Realdon Italy 21 309 0.9× 404 1.3× 49 0.2× 107 0.6× 312 2.2× 75 1.4k
Zenichi Morise Japan 22 260 0.8× 491 1.6× 95 0.4× 70 0.4× 215 1.5× 92 1.5k

Countries citing papers authored by Tomer Adar

Since Specialization
Citations

This map shows the geographic impact of Tomer Adar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomer Adar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomer Adar more than expected).

Fields of papers citing papers by Tomer Adar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomer Adar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomer Adar. The network helps show where Tomer Adar may publish in the future.

Co-authorship network of co-authors of Tomer Adar

This figure shows the co-authorship network connecting the top 25 collaborators of Tomer Adar. A scholar is included among the top collaborators of Tomer Adar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomer Adar. Tomer Adar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adar, Tomer, et al.. (2023). Increased hepatic Akt phosphorylation alleviated glucose intolerance and improved liver function in leptin-deficient mice. Clinical and Experimental Hepatology. 9(2). 154–171. 1 indexed citations
2.
Adar, Tomer, Ravi S. Lankalapalli, Robert Bittman, & Yaron Ilan. (2020). The assembly of glycosphingolipid determines their immunomodulatory effect: A novel method for structure-based design of immunotherapy. Cellular Immunology. 355. 104157–104157. 4 indexed citations
3.
Mizrahi, Meir, et al.. (2019). Oral Administration of Hoodia parviflora Alleviates Insulin Resistance and Nonalcoholic Steatohepatitis. Journal of Medicinal Food. 22(12). 1189–1198. 4 indexed citations
4.
Adar, Tomer, Linda Rodgers, Kristen M. Shannon, et al.. (2018). Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome. Cancer. 124(15). 3145–3153. 63 indexed citations
5.
Mizrahi, Meir, Tomer Adar, Gadi Lalazar, et al.. (2018). Glycosphingolipids Prevent APAP and HMG-CoA Reductase Inhibitors-mediated Liver Damage: A Novel Method for “Safer Drug” Formulation that Prevents Drug-induced Liver Injury. Journal of Clinical and Translational Hepatology. 6(2). 1–8. 12 indexed citations
6.
Adar, Tomer. (2017). E‐learning in gastroenterology—What have we learned so far?. United European Gastroenterology Journal. 5(4). 603–604. 3 indexed citations
7.
Adar, Tomer, Linda Rodgers, Kristen M. Shannon, et al.. (2017). A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndrome. Modern Pathology. 30(3). 440–447. 48 indexed citations
8.
Lieberman, Sari, Tom Walsh, Tomer Adar, et al.. (2017). Features of Patients With Hereditary Mixed Polyposis Syndrome Caused by Duplication of GREM1 and Implications for Screening and Surveillance. Gastroenterology. 152(8). 1876–1880.e1. 25 indexed citations
9.
Shitrit, Ariella Bar‐Gil, Benjamin Koslowsky, Dan M. Livovsky, et al.. (2016). A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy. Scandinavian Journal of Gastroenterology. 52(3). 328–333. 26 indexed citations
10.
Adar, Tomer, et al.. (2016). Young GI Angle: Young physicians and researchers within UEG – Perspectives and a toolbox for future development. United European Gastroenterology Journal. 4(1). 156–157.
11.
Adar, Tomer, Yaron Ilan, Deborah Elstein, & Ari Zimran. (2016). Liver involvement in Gaucher disease – Review and clinical approach. Blood Cells Molecules and Diseases. 68. 66–73. 33 indexed citations
12.
Dotan, Iris, Etgar Levy‐Nissenbaum, Yehuda Chowers, et al.. (2016). Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial. Digestive Diseases and Sciences. 61(11). 3246–3254. 10 indexed citations
13.
Shitrit, Ariella Bar‐Gil, et al.. (2015). P241. Limitations in using fecal Calprotectin as a biomarker of IBD disease activity during Pregnancy. Journal of Crohn s and Colitis. 9(suppl 1). S196–S196. 3 indexed citations
14.
Shitrit, Ariella Bar‐Gil, Benjamin Koslowsky, Michal Kori, et al.. (2015). Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 21(3). 631–635. 8 indexed citations
15.
Adar, Tomer, Sorina Grisaru‐Granovsky, Ami Ben Yaʼacov, Eran Goldin, & Ariella Bar‐Gil Shitrit. (2015). Pregnancy and the Immune System: General Overview and the Gastroenterological Perspective. Digestive Diseases and Sciences. 60(9). 2581–2589. 24 indexed citations
16.
Adar, Tomer, et al.. (2014). From airway inflammation to inflammatory bowel disease: Eotaxin-1, a key regulator of intestinal inflammation. Clinical Immunology. 153(1). 199–208. 56 indexed citations
17.
18.
Mizrahi, Meir, Gadi Lalazar, Tomer Adar, Itamar Raz, & Yaron Ilan. (2010). Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients. Nutrition Journal. 9(1). 25–25. 21 indexed citations
19.
Lalazar, Gadi, Tomer Adar, & Yaron Ilan. (2009). Point-of-care continuous13C-methacetin breath test improves decision making in acute liver disease: Results of a pilot clinical trial. World Journal of Gastroenterology. 15(8). 966–966. 23 indexed citations
20.
Mizrahi, Meir, Tomer Adar, Daniel Shouval, Allan I. Bloom, & Oren Shibolet. (2009). Endotipsitis-persistent infection of transjugular intrahepatic portosystemic shunt: pathogenesis, clinical features and management. Liver International. 30(2). 175–183. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kunihiko Murase Breakdown of academic impact, for papers by Nasir Mahmud Breakdown of academic impact, for papers by Kazuo Ohba Breakdown of academic impact, for papers by Ömer Özbakır Breakdown of academic impact, for papers by Mine Güllüoğlu Breakdown of academic impact, for papers by Dajun Qian Breakdown of academic impact, for papers by James L. Wisecarver Breakdown of academic impact, for papers by Ali Tüzün İnce Breakdown of academic impact, for papers by Stefano Realdon Breakdown of academic impact, for papers by Zenichi Morise
Rankless by CCL
2026